Work

Pure Erythroid Leukemia in a Sickle Cell Patient Treated with Hydroxyurea

Year: 2020

Type: article

Abstract: We present a very rare case of pure erythroid leukemia arising in a young patient with sickle cell disease being treated with hydroxyurea for almost 5 years. Diagnosing and managing this rare condition has been a challenge and the majority of patients with pure erythroid leukemia have a very poor prognosis with survival in months despite treatment. This form of leukemia could be therapy related and in our case, hydroxyurea may have been responsible for the development of this aggressive condition.

Source: Case Reports in Oncology

DOI: 10.1159/000508361

Authors: Dhiraj Kumar Yadav, Thushara Paul, Mohamed Alhamar, Kedar Inamdar, Yue Guo

Institutions: Henry Ford Health, Henry Ford Hospital

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,170